An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer.
|Articles|October 6, 2015
Amanda L. Kong on Seeking a Second Opinion for Breast Cancer Care at a High Volume Hospital
Author(s)Amanda L. Kong
Amanda L. Kong, discusses why patients should consider seeking a second opinion for their breast cancer diagnosis and care at a high volume hospital.
Advertisement
Amanda L. Kong, associate professor, Department of Surgery, Medical College of Wisconsin, discusses why patients should consider seeking a second opinion for their breast cancer diagnosis and care at a high volume hospital.
Advertisement
Related to this article
After breast cancer at 30, Aisha shares her journey through motherhood, a double mastectomy, body image struggles and the challenges of survivorship.
Joy Maulik, MSN, FNP-C, explains why a prostate cancer diagnosis should be seen as a change in direction, not an ending, and how patients can lean on education, their providers and caregivers.
Dr. Morana Vojnic answers common questions about brain cancer, including diagnosis, tumor types, treatment effects, recurrence and life after treatment begins.
Longer follow-up presented at the 2026 ESMO Congress showed that four already-approved treatments for early breast cancer, kidney cancer, colorectal cancer and stomach and esophageal cancer kept helping patients years later.
Dr. Jacqueline Barrientos shares how a targeted therapy, a determined care team and a stranger’s generosity gave a 72-year-old man with hairy cell leukemia and kidney failure a second chance.
Two phase 3 trials at ESMO 2026 brought new options for advanced endometrial cancer, and final results for Verzenio after another CDK4/6 drug showed a survival difference that was not statistically significant.
Dr. Robert Kreitman explains how CD22-targeted CAR T could help heavily pretreated patients.
Advertisement
Advertisement
Trending on CURE
1
3 Quality-of-Life Results From ESMO 2026 Patients Should Know
2
4 Long-Term Survival Results From ESMO 2026 Patients Should Know
3
3 ESMO 2026 Results in Endometrial and Breast Cancer to Know
4
Neuro-Oncologist Answers Common Questions About Brain Cancer Diagnosis and Treatment
5